Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
770.00 | -48,73% | -27,69% | 693.312,15 | 0,67% | 2,63% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
903.30 | -1,06% | 19,47% | 4.007.181,69 | 1,03% | 18,5% |
|
NYSE:JNJ
Johnson & Johnson
|
154.64 | 0% | 0% | 372.168,87 | 3,21% | 2,71% |
|
NYSE:MRK
Merck
|
131.19 | -10,02% | 3,18% | 332.278,86 | 2,35% | -19,03% |
|
NYSE:ABBV
AbbVie
|
166.42 | -23,06% | -12,89% | 293.875,72 | 3,77% | 7,03% |
|
LSE:AZN
AstraZeneca PLC
|
121.10 | 18,89% | 41,61% | 187.733,46 | 2,01% | 15,98% |
|
SWX:NOVN
Novartis
|
93.37 | 8,15% | 21,52% | 190.512,74 | 3,56% | 4,67% |
|
NasdaqGS:AMGN
Amgen
|
312.47 | -12,26% | -3,47% | 167.619,75 | 2,86% | 5,31% |
|
ASX:CSL
CSL
|
280.00 | 22,59% | 43,54% | 135.310,76 | 1,23% | 7,18% |
|
LSE:GSK
GSK
|
17.75 | 7,44% | 23,26% | 72.385,16 | 3,25% | 0,79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.03 | 61,74% | 72,08% | 89.253,22 | 5,44% | 13,54% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.72 | 20,9% | 30,15% | 84.363,86 | 4,54% | 0,15% |
|
NYSE:MMM
3M
|
105.26 | 58,01% | 72,94% | 58.246,81 | 5,76% | -2,45% |
|
NasdaqGS:MRNA
Moderna
|
132.90 | -.110,71% | -.107,39% | 50.932,56 | 0% | 0% |
|
SWX:LONN
Lonza Group
|
529.20 | -28,51% | -13,47% | 38.164,1 | 0,76% | 0,68% |
|
NYSE:CTVA
Corteva
|
56.45 | 18,19% | 39,33% | 39.344,3 | 1,14% | 17,11% |
|
XTRA:BEI
Beiersdorf
|
144.70 | -1,49% | 9,6% | 32.386,61 | 0,69% | 3,11% |
|
NasdaqGS:BIIB
Biogen
|
230.57 | -15,23% | -0,18% | 33.570,28 | 0% | -10,89% |
|
XTRA:BAYN
Bayer
|
28.58 | 67,53% | 83,89% | 28.077,68 | 0,38% | 1,47% |
|
CPSE:COLO B
Coloplast A/S
|
850.00 | 17,48% | 35,86% | 191.114,05 | 2,5% | 4,41% |
